CMR Surgical Appoints Industry Veteran to Lead Operations in Asia Pacific, Middle East, and Africa

19 February 2024 | Monday | News

Experienced Healthcare Leader Sushobhan Dasgupta to Drive CMR Surgical's Expansion in Key Global Markets
Image Source | Public Domain

Image Source | Public Domain

CMR Surgical (CMR), a global leader in surgical robotics, has announced the appointment of Sushobhan Dasgupta as President and Chief Commercial Officer for Asia Pacific, the Middle East, and Africa. With over 30 years of experience in the global healthcare sector, including an extensive tenure at Johnson & Johnson (J&J), Dasgupta brings a wealth of expertise to CMR Surgical.

Having most recently served as Vice Chairman and Global President at Shalby Limited, Dasgupta has demonstrated his leadership in driving growth and strategic oversight in the healthcare industry. His distinguished career at J&J, where he held various leadership roles, further solidifies his position as a respected figure within the sector.

Supratim Bose, CEO of CMR Surgical, expressed confidence in Dasgupta's appointment, highlighting the rapid growth of surgical robotics in the targeted regions. Bose stated, "Asia Pacific, the Middle East, and Africa are witnessing significant growth in the adoption of surgical robotics. With Sushobhan's extensive experience and strong industry reputation, we are poised to capitalize on these opportunities and expand our presence."

Dasgupta, in his new role, expressed enthusiasm for CMR Surgical's innovative product, Versius, and its potential to meet the growing demand for surgical robotics. He emphasized the company's commitment to driving commercial success and improving patient care across the regions.

The appointment of Dasgupta follows CMR Surgical's impressive achievements in 2023, including over 50% growth in its global install base and the successful completion of over 19,000 surgical cases with Versius.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close